Skip to main content
HERAMED LIMITED logo

HERAMED LIMITED — Investor Relations & Filings

Ticker · HMD ISIN · AU0000028367 LEI · 875500WOB41XBFTTJ477 ASX Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2021-12-06 Capital/Financing Update
Country AU Australia
Listing ASX HMD

About HERAMED LIMITED

https://hera-med.com/

HeraMED Limited is a medical technology company specializing in the development and commercialization of digital health solutions for maternity care. The company focuses on providing remote monitoring tools that bridge the gap between expectant mothers and healthcare providers. Its flagship product, HeraBEAT, is a medical-grade, smartphone-based fetal heart rate monitor designed for home use, allowing for accurate and reliable monitoring of fetal well-being. This hardware is integrated into the HeraCARE platform, a comprehensive digital maternity care solution that enables remote data management, personalized care plans, and seamless communication between patients and clinicians. By leveraging cloud-based technology and advanced sensors, the company aims to enhance prenatal care, improve clinical outcomes, and offer peace of mind through continuous, data-driven insights throughout the pregnancy journey.

Recent filings

Filing Released Lang Actions
Cleansing Notice 1 page 119.0KB
Capital/Financing Update Classification · 95% confidence The document is a short announcement dated 7 December 2021 regarding the issuance of fully paid ordinary shares following the exercise of options by HeraMED Limited. It references compliance with section 708A(5)(e) of the Corporations Act and confirms that the shares were issued without disclosure under Part 6D.2 of the Act. The document is brief (2167 characters) and does not contain any financial statements, detailed financial data, or management discussion. It is a regulatory announcement about a capital transaction (exercise of options and share issuance) rather than a full financial report or detailed capital update. Given the nature of the content—announcement of share issuance due to option exercise and compliance notice under the Corporations Act—this fits best under Capital/Financing Update (CAP).
2021-12-06 English
Change of Director's Interest Notice x 3 6 pages 496.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by company directors, including acquisitions and disposals of shares and options. The content is focused on personal share transactions by directors, including exercise of options and changes in shareholdings. There is no financial performance data, earnings information, or management discussion. The document is a formal notification of insider trades by directors, which aligns with the definition of Director's Dealing filings.
2021-12-06 English
Positive Interim Results in HeraCARE Paid Pilot - Joondalup 3 pages 176.4KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 2 December 2021, providing an update on the progress of a paid pilot program for HeraCARE at Joondalup Health Campus. It details interim results, patient engagement statistics, and collaboration with the hospital. The content focuses on operational progress and clinical validation rather than financial results or regulatory filings. There is no indication of financial statements, earnings data, or regulatory certifications. The document is a corporate announcement about a pilot program's progress and results, which fits best under a general regulatory announcement category rather than a financial report or management discussion. It is not a report publication announcement since it contains substantive information rather than just announcing a report release. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2021-12-01 English
Application for quotation of securities - HMD 8 pages 31.6KB
Share Issue/Capital Change Classification · 100% confidence The document is an application for quotation of securities on the ASX, detailing the issuance and conversion of options into ordinary fully paid shares. It includes specifics about the number of securities, issue dates, prices, and the resulting issued capital. There is no financial performance data, management discussion, or regulatory certification. The content focuses on the issuance and quotation of new shares following option exercises, which aligns with announcements about share issues or capital changes. Therefore, the document fits the category of Share Issue/Capital Change (SHA). The document length and detail confirm it is not a mere announcement of a report but a substantive filing about capital changes.
2021-12-01 English
Cleansing Notice 1 page 142.5KB
Share Issue/Capital Change Classification · 95% confidence The document is a notice regarding the issuance of shares following the exercise of options by HeraMED Limited. It references compliance with section 708A(5)(e) of the Corporations Act and provides details about the share issuance and legal compliance. The document is short (2075 characters) and serves as an announcement of a capital change event rather than a full financial report or detailed analysis. It does not contain financial statements or detailed financial data. Therefore, it fits the category of a Share Issue/Capital Change announcement.
2021-12-01 English
Notice of General Meeting/Proxy Form 14 pages 457.8KB
AGM Information Classification · 100% confidence The document is titled 'NOTICE OF GENERAL MEETING' for Heramed Limited and includes detailed agenda items for shareholder resolutions, including ratification and approval of convertible notes and options issuance. It contains proxy voting instructions, explanatory statements, and references to ASX Listing Rules related to shareholder approvals for securities issuance. The content is typical of a formal notice sent to shareholders prior to a general meeting to inform them of the business to be conducted and to solicit votes. There is no financial data, earnings information, or management discussion of results. It is not a report or transcript but a meeting notice with resolutions to be voted on. Therefore, this document fits the category of AGM Information (AGM-R).
2021-11-17 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.